| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |